AN2 Therapeutics, Inc.
ANTX
$1.25
-$0.04-3.10%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -10.50% | -10.63% | -8.47% | 6.44% | -13.34% |
Total Receivables | -70.00% | 233.33% | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -28.16% | 25.60% | 23.54% | 16.06% | -30.07% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -11.70% | -9.07% | -7.63% | 5.25% | -12.58% |
|
|||||
Total Current Assets | -11.70% | -9.07% | -7.63% | 5.25% | -12.58% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 0.00% | 0.00% | 0.00% |
Total Assets | -5.73% | -9.95% | -10.54% | -12.60% | -9.79% |
|
|||||
Total Accounts Payable | 93.86% | -9.23% | -22.52% | -9.08% | -45.13% |
Total Accrued Expenses | -12.81% | -8.49% | -2.86% | -26.08% | 19.06% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -37.96% | 128.09% | 74.14% | -51.95% | -31.56% |
Total Other Current Liabilities | -37.96% | 128.09% | 74.14% | -51.95% | -31.56% |
Total Current Liabilities | 2.21% | -1.09% | -5.03% | -24.07% | -5.36% |
|
|||||
Total Current Liabilities | 2.21% | -1.09% | -5.03% | -24.07% | -5.36% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.21% | -1.09% | -5.03% | -24.07% | -5.36% |
|
|||||
Common Stock & APIC | 0.62% | 0.68% | 0.81% | 0.98% | 0.81% |
Retained Earnings | -3.79% | -6.87% | -8.44% | -10.76% | -12.28% |
Treasury Stock & Other | -72.32% | 514.81% | -150.94% | -80.73% | 325.41% |
Total Common Equity | -6.64% | -10.86% | -11.07% | -11.31% | -10.27% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -6.64% | -10.86% | -11.07% | -11.31% | -10.27% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6.64% | -10.86% | -11.07% | -11.31% | -10.27% |
|